Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Morgan Stanley says buy these quality stocks. They also pay dividends
Gilead Sciences (GILD) Expected to Post Quarterly Earnings on Monday
Gilead Sciences, Inc. $GILD Shares Bought by KCM Investment Advisors LLC
Quantinno Capital Management LP Buys 117,534 Shares of Gilead Sciences, Inc. $GILD - Markets Daily
Empowered Funds LLC Has $27.24 Million Stake in Gilead Sciences, Inc. $GILD - Zolmax
Empowered Funds LLC Increases Holdings in Gilead Sciences, Inc. $GILD - Daily Political
Morgan Stanley Has Lowered Expectations for Gilead Sciences (NASDAQ:GILD) Stock Price
AstraZeneca Pressure Puts Krystal Biotech, TG Therapeutics And Gilead Stocks In Focus
#Aids2026: Daily pill. Monthly pill. Six-monthly jab. Why choice matters
Wealth Alliance LLC Sells 4,400 Shares of Gilead Sciences, Inc. $GILD - Markets Daily
Orbimed Advisors LLC Buys New Shares in Gilead Sciences, Inc. $GILD
Wealth Alliance LLC Cuts Stake in Gilead Sciences, Inc. $GILD - Stock Observer
Gilead (GILD) Wins Key Europe Backing For Trodelvy In Triple Negative Breast Cancer
Gilead Sciences, Inc. $GILD Shares Sold by Lombard Odier Asset Management Europe Ltd - Daily Political
OMERS ADMINISTRATION Corp Has $162.10 Million Stake in Gilead Sciences, Inc. $GILD - Daily Political
Best Pharmaceutical Stocks To Watch Now - July 25th
Gilead Sciences (GILD) Gets a Hold from RBC Capital
Hilltop Holdings Inc. Sells 8,156 Shares of Gilead Sciences, Inc. $GILD
Hilltop Holdings Inc. Reduces Stake in Gilead Sciences, Inc. $GILD - Zolmax
Epoch Investment Partners Inc. Sells 47,960 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Dai ichi Life Insurance Company Ltd Sells 13,858 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Pharmaceutical Stocks Worth Watching - July 21st - Zolmax
PNC Financial Services Group Inc. Has $67.77 Million Stock Position in Gilead Sciences, Inc. $GILD - Markets Daily
Public Employees Retirement System of Ohio Has $78.86 Million Stake in Gilead Sciences, Inc. $GILD - Stock Observer
Bank of Nova Scotia Decreases Stock Position in Gilead Sciences, Inc. $GILD
Sei Investments Co. Has $161.41 Million Position in Gilead Sciences, Inc. $GILD - Daily Political
Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study
Gilead Sciences, Inc. $GILD Shares Purchased by NewEdge Wealth LLC - Markets Daily
NewEdge Wealth LLC Raises Stake in Gilead Sciences, Inc. $GILD - Zolmax
Meiji Yasuda America Inc Increases Holdings in Gilead Sciences, Inc. $GILD - Markets Daily
Gilead Sciences, Inc. $GILD Holdings Decreased by Westpac Banking Corp
First Trust Advisors LP Buys 1,683,586 Shares of Gilead Sciences, Inc. $GILD
Gilead (GILD) Stock Could Still Trade At A Discount Following Its 127% Run
Gilead Sciences, Inc. $GILD Shares Bought by Meiji Yasuda America Inc - Stock Observer
Oslo Pensjonsforsikring AS Makes New $648,000 Investment in Gilead Sciences, Inc. $GILD - Stock Observer
Florida Financial Advisors LLC Lowers Position in Gilead Sciences, Inc. $GILD - Stock Observer
Gilead (GILD) Will Bring New HIV Data And A Merck Regimen To AIDS 2026
Gilead Sciences to Release Second Quarter 2026 Financial Results on Tuesday, August 4, 2026 | Morningstar
GILD: Once-Weekly Oral HIV Regime Maintains Virologic Suppression At Week 48
Pharmaceutical Stocks Worth Watching - July 21st - Stock Observer
Gilead Sciences' Quarterly Earnings Preview: What You Need to Know
Here Are Tuesday's Top Wall Street Analyst Research Calls: Adobe, Datadog, Five Below, Fortinet, Gilead Sciences, Goldman Sachs, Microsoft, Salesforce, and More
Summit Global Investments Trims Stock Position in Gilead Sciences, Inc. $GILD - Markets Daily
Summit Global Investments Cuts Holdings in Gilead Sciences, Inc. $GILD
Independent Financial Group LLC Takes Position in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Position Decreased by Convergence Investment Partners LLC
Gilead Sciences (NASDAQ:GILD) Downgraded by Leerink Partners to Market Perform - Daily Political
DJE Kapital AG Cuts Stock Holdings in Gilead Sciences, Inc. $GILD - Daily Political
Mosaic chromosomal alterations are suppressed in older adults with HIV
KBC Group NV Has $373.46 Million Stock Position in Gilead Sciences, Inc. $GILD - Zolmax
Pharmaceutical Stocks To Research - July 20th - Daily Political
KBC Group NV Has $373.46 Million Stake in Gilead Sciences, Inc. $GILD
Dimensional Fund Advisors LP Lowers Stock Holdings in Gilead Sciences, Inc. $GILD
FY2026 EPS Forecast for Gilead Sciences Boosted by Analyst
Swiss National Bank Buys 240,800 Shares of Gilead Sciences, Inc. $GILD
SEB Asset Management AB Invests $171.84 Million in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Sold by Financiere des Professionnels Fonds d investissement inc. - Markets Daily
Dorsey Wright & Associates Acquires New Stake in Gilead Sciences, Inc. $GILD - Markets Daily
Swiss National Bank Has $507.45 Million Holdings in Gilead Sciences, Inc. $GILD - Stock Observer
Assetmark Inc. Cuts Stock Position in Gilead Sciences, Inc. $GILD
Jennison Associates LLC Has $176.24 Million Stake in Gilead Sciences, Inc. $GILD - Stock Observer
Gilead Stock Tops 3 GARP Picks Trading On More Measured Valuations
Gilead Sciences synthesizes new KRAS mutant inhibitors
Jag Capital Management LLC Increases Stake in Gilead Sciences, Inc. $GILD
Sigma Planning Corp Sells 7,783 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Bought by D.A. Davidson & CO.
Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia
Is Gilead Sciences (GILD) Fully Valued Following Mixed Earnings And A Full Year EPS Miss?
Sanctuary Advisors LLC Cuts Stock Holdings in Gilead Sciences, Inc. $GILD
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial
Is the Bearishness Around Pfizer and Gilead Sciences a Contrarian Opportunity?
Should Gilead's Revenue Beat but Softer EPS Outlook Require Action From Gilead Sciences (GILD) Investors?
Diversify Wealth Management LLC Acquires 5,072 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Bleakley Financial Group LLC Acquires 24,649 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Calamos Advisors LLC Raises Stock Holdings in Gilead Sciences, Inc. $GILD
J. Safra Sarasin Holding AG Lowers Stock Position in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. (NASDAQ:GILD) Given Average Rating of "Moderate Buy" by Analysts - Zolmax
Gilead Sciences, Inc. (NASDAQ:GILD) Receives Consensus Rating of "Moderate Buy" from Brokerages
AMF Tjanstepension AB Buys 17,302 Shares of Gilead Sciences, Inc. $GILD
Procyon Advisors LLC Increases Stock Position in Gilead Sciences, Inc. $GILD - Stock Observer
Teachers Retirement System of The State of Kentucky Has $85.62 Million Holdings in Gilead Sciences, Inc. $GILD - Daily Political
Gilead Sciences (NASDAQ:GILD) Raised to Buy at Wall Street Zen
Gilead Sciences (NASDAQ:GILD) Rating Increased to Buy at Wall Street Zen
Fifth Third Bancorp Purchases 226,510 Shares of Gilead Sciences, Inc. $GILD
Wells Fargo Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)
Candriam S.C.A. Has $232.79 Million Holdings in Gilead Sciences, Inc. $GILD
Conning Inc. Decreases Position in Gilead Sciences, Inc. $GILD
Gilead Sciences Down Over 4%, on Pace for Largest Percent Decrease Since July 2025 - Data Talk | Morningstar
Ibex Wealth Advisors Has $2.14 Million Holdings in Gilead Sciences, Inc. $GILD
Gilead (GILD) Stock Looks Below Fair Value But Earnings Already Look Priced In
Gilead News
XRP Price Prediction 2026, 2027, 2030 & 2040 | How High Can XRP Go?
EUR/USD Forecast 2026 & Beyond: Will the US Dollar Strengthen Against the Euro?
Latest news
Show more
Gold Price Today, July 29: Gold Holds Above $4,020 Ahead of Fed Decision
Fed Rate Decision Preview July 30: Wall Street Braces for One of the Most Uncertain FOMC Meetings in Years
Amazon Earnings Date July 30: AWS Growth and $200 Billion AI Spending in Focus Ahead of Q2 Results
SK Hynix Q2 Earnings Miss Lofty Forecasts Despite Record Profit as HBM4 Ramps Up
